🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Softgel(s) Serving Size
20 Servings
Fat/Fatty Acid Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
4 Gram(s) (5% DV)
Cholesterol
10 mg (3% DV)
1200 mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1200mg UL 3000mg
Olive Oil
1200 mg
1200 mg
📊 Market median: 1000.0mg (212 products) 📚 12 studies (Tier A: 0, B: 3)
This product: 1200mg

Other Ingredients

Gelatin Glycerin Water, Purified

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take 3 Softgels daily, with a meal as a dietary supplement, or as directed by a healthcare professional.

⚠️ Warnings & Precautions

Keep out of reach of children.

Do not use if seal is broken.

Contains: Fish.

🧪 Formulation Notes

Essential EPA, DHA, ALA, Oleic Fish Oil, Flaxseed oil & Olive Oil

Supports: Joint Health, Cardiovascular

Essential Fatty Acids

Additional Information

Store in a cool, dry place. Protect from heat, light and moisture.

Product Details

UPC / SKU 0 35046 05974 3
DSLD Entry Date 2024-04-23
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand OmegaWorks
DSLD ID 307861
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →